Roadshow
ACTOnco+
ACTOnco®+ is a comprehensive genomic profiling (CGP) solution for solid tumors, designed to support precision oncology across the entire treatment journey—from newly diagnosed patients to those with locally advanced, metastatic, recurrent, or treatment-resistant disease. Performed in our CAP-accredited laboratory, the assay analyzes over 400 cancer-related genes using ultra-deep NGS sequencing (≥500× mean depth), providing comprehensive detection of SNVs, InDels, CNVs, gene fusions, Tumor Mutational Burden (TMB), and Microsatellite Instability (MSI).
ACTOnco®+ combines proprietary macrodissection technology, advanced bioinformatics, and pathway-based analysis to improve variant detection accuracy and translate complex genomic data into clinically actionable insights. Our reports integrate targeted therapy options, immunotherapy biomarkers, and molecular pathway interpretation to support personalized treatment selection and clinical trial matching. Every report is complemented by consultation with our medical team, ensuring meaningful clinical interpretation.
/ACTOnco_plus_%E8%87%A8%E5%BA%8A%E6%87%89%E7%94%A8%E5%84%AA%E5%8B%A2_%E5%AE%8C%E6%95%B4%E9%A0%81%E9%9D%A2_300dpi.jpg)
With an industry-leading turnaround time of just 8 working days, ACTOnco®+ empowers physicians with timely, reliable, and evidence-based genomic information for confident clinical decision-making.
/ACTOnco_plus_%E5%AE%8C%E6%95%B4%E5%A0%B1%E5%91%8A%E5%84%AA%E5%8B%A2_%E5%AE%8C%E6%95%B4%E9%A0%81%E9%9D%A2_300dpi.jpg)
- Established 2013
- Company ACT Genomics Co., Ltd.
- Telephone +886 2-2795-3660
- Email skytsang@actgenomics.com
- Address 3F, No. 345, Xinhu 2nd Rd., Neihu Dist., Taipei City 114065, Taiwan (R.O.C.)
ACT Genomics is a precision oncology company specializing in next-generation sequencing (NGS)-based genomic testing. Through our CAP-accredited laboratory, FDA-cleared solutions, proprietary genomic database, and advanced bioinformatics, we deliver comprehensive genomic profiling that supports cancer diagnosis, treatment selection, therapy monitoring, and clinical trial matching. Our clinically actionable reports combine intuitive data visualization with expert interpretation, enabling physicians to make confident treatment decisions. ACT Genomics partners with healthcare providers worldwide through flexible collaboration models, including international testing services and technology transfer.